Source: International Congress 2019 – Pulmonary hypertension: clinical
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Oliveira (SP, Brazil), D. Calderaro (SP, Brazil), B. Piloto (SP, Brazil), M. Castro (SP, Brazil), S. Hoette (SP, Brazil), C. Jardim (SP, Brazil), R. Souza (SP, Brazil), C. Fernandes (SP, Brazil). Platelets and pulmonary arterial hypertension (PAH). 4756

Member's Comments

No comment yet.

Related content which might interest you: Pregnancy and pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension II Year: 2013 Is there a fixed relationship between the mean and systolic pulmonary artery pressures in idiopathic pulmonary arterial hypertension (IPAH) and proximal chronic thromboembolic pulmonary hypertension (CTEPH) Source: Annual Congress 2009 - Pulmonary embolism Year: 2009 6MWD in patients with pulmonary arterial hypertension (PAH) Source: Eur Respir J 2003; 22: Suppl. 45, 464s Year: 2003 Endothelium in pulmonary arterial hypertension Source: Annual Congress 2007 - Role of the endothelium in pulmonary function and disease Year: 2007 Pulmonary arterial hypertension Source: Eur Respir Monogr 2013; 62: 70-84 Year: 2013 Pulmonary arterial hypertension Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases Year: 2018 Pulmonary arterial hypertension Source: ISSN=ISSN 1810-6838, ISBN=, page=126 Year: 2005 Pulmonary arterial hypertension Source: Eur Respir Monogr 2014; 66: 232-246 Year: 2014 Pulmonary arterial hypertension Source: Breathe 2010; 6: 377-380 Year: 2010 Pulmonary arterial hypertension Source: ISSN=ISSN 1810-6838, ISBN=, page=397 Year: 2007 Exhaled breath olfactory signature of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) Source: Virtual Congress 2020 – Pathophysiology of pulmonary hypertension Year: 2020 Pulmonary artery pulse pressure in chronic thromboembolic pulmonary hypertension (CTEPH) Source: Eur Respir J 2006; 28: Suppl. 50, 399s Year: 2006 Exercise limitation in idiopathic pulmonary arterial hypertension (IPAH): there‘s more to it than just the pulmonary circulation Source: Eur Respir J 2005; 26: Suppl. 49, 560s Year: 2005 Effect of riociguat on pulmonary arterial compliance in patients with pulmonary arterial hypertension (PAH) in the RESPITE study Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials Year: 2017 Single arterial occlusion to locate resistance in patients with pulmonary hypertension Source: Eur Respir J 2003; 21: 31-36 Year: 2003 Pulmonary arterial hypertension in children Source: Eur Respir J 2003; 21: 155-176 Year: 2003 Endothelial cell mechanics are altered in pulmonary arterial hypertension (PAH) Source: Annual Congress 2011 - Experimental pulmonary hypertension Year: 2011 Risk stratification in pulmonary arterial hypertension (PAH) Source: International Congress 2018 – New trends in the management of pulmonary hypertension Year: 2018 Riociguat for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH): Final data from a phase II long-term extension (LTE) study Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots Year: 2015 Effect of riociguat on haemodynamic parameters and exercise capacity in patients with chronic thromboembolic pulmonary hypertension (CTEPH) and pulmonary arterial hypertension (PAH) Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009